Annual SGA
$195.04 M
-$1.33 M-0.68%
December 31, 2023
Summary
- As of February 7, 2025, AUPH annual SGA is $195.04 million, with the most recent change of -$1.33 million (-0.68%) on December 31, 2023.
- During the last 3 years, AUPH annual SGA has risen by +$97.76 million (+100.51%).
- AUPH annual SGA is now -0.68% below its all-time high of $196.37 million, reached on December 31, 2022.
Performance
AUPH SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$39.64 M
-$2.64 M-6.24%
September 30, 2024
Summary
- As of February 7, 2025, AUPH quarterly SGA is $39.64 million, with the most recent change of -$2.64 million (-6.24%) on September 30, 2024.
- Over the past year, AUPH quarterly SGA has dropped by -$2.64 million (-6.24%).
- AUPH quarterly SGA is now -34.61% below its all-time high of $60.62 million, reached on December 31, 2023.
Performance
AUPH Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$3.79 B
-$22.55 M-0.60%
September 30, 2024
Summary
- As of February 7, 2025, AUPH TTM SGA is -$3.79 billion, with the most recent change of -$22.55 million (-0.60%) on September 30, 2024.
- Over the past year, AUPH TTM SGA has dropped by -$3.98 billion (-2069.43%).
- AUPH TTM SGA is now -68704.13% below its all-time high of -$5.50 million.
Performance
AUPH TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
AUPH Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.7% | -6.2% | -2069.4% |
| 3 y3 years | +100.5% | -24.0% | -2054.8% |
| 5 y5 years | +1324.2% | -24.0% | -2054.8% |
AUPH Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -0.7% | +12.4% | -34.6% | at low | -36.3% | at low |
| 5 y | 5-year | -0.7% | +773.1% | -34.6% | +433.5% | -129.6% | at low |
| alltime | all time | -0.7% | >+9999.0% | -34.6% | >+9999.0% | <-9999.0% | at low |
Aurinia Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $39.64 M(-6.2%) | $187.39 M(-2.5%) |
| Jun 2024 | - | $42.28 M(-5.7%) | $192.22 M(-0.7%) |
| Mar 2024 | - | $44.85 M(-26.0%) | $193.59 M(-0.7%) |
| Dec 2023 | $195.04 M(-0.7%) | $60.62 M(+36.3%) | $195.04 M(+7.2%) |
| Sep 2023 | - | $44.48 M(+1.9%) | $181.89 M(-4.1%) |
| Jun 2023 | - | $43.64 M(-5.7%) | $189.59 M(-4.0%) |
| Mar 2023 | - | $46.30 M(-2.5%) | $197.48 M(+0.6%) |
| Dec 2022 | $196.37 M(+13.2%) | $47.47 M(-9.0%) | $196.37 M(+1.4%) |
| Sep 2022 | - | $52.17 M(+1.2%) | $193.66 M(+4.0%) |
| Jun 2022 | - | $51.53 M(+14.0%) | $186.14 M(+4.0%) |
| Mar 2022 | - | $45.20 M(+1.0%) | $178.93 M(+3.1%) |
| Dec 2021 | $173.54 M(+78.4%) | $44.76 M(+0.3%) | $173.54 M(+2.8%) |
| Sep 2021 | - | $44.65 M(+0.7%) | $168.84 M(+9.0%) |
| Jun 2021 | - | $44.32 M(+11.3%) | $154.90 M(+22.9%) |
| Mar 2021 | - | $39.80 M(-0.7%) | $126.02 M(+29.6%) |
| Dec 2020 | $97.27 M(+335.5%) | $40.07 M(+30.5%) | $97.27 M(+50.5%) |
| Sep 2020 | - | $30.70 M(+98.7%) | $64.63 M(+61.6%) |
| Jun 2020 | - | $15.45 M(+39.8%) | $39.99 M(+35.6%) |
| Mar 2020 | - | $11.05 M(+48.8%) | $29.49 M(+32.0%) |
| Dec 2019 | $22.34 M(+63.1%) | $7.43 M(+22.6%) | $22.34 M(+21.2%) |
| Sep 2019 | - | $6.06 M(+22.5%) | $18.43 M(+20.5%) |
| Jun 2019 | - | $4.95 M(+26.8%) | $15.29 M(+10.8%) |
| Mar 2019 | - | $3.90 M(+10.9%) | $13.80 M(+0.8%) |
| Dec 2018 | $13.69 M(+13.2%) | $3.52 M(+20.4%) | $13.69 M(+3.0%) |
| Sep 2018 | - | $2.92 M(-15.6%) | $13.29 M(+2.1%) |
| Jun 2018 | - | $3.46 M(-8.7%) | $13.02 M(+4.5%) |
| Mar 2018 | - | $3.79 M(+21.6%) | $12.46 M(+3.0%) |
| Dec 2017 | $12.10 M(+73.5%) | $3.12 M(+17.7%) | $12.10 M(+8.0%) |
| Sep 2017 | - | $2.65 M(-8.7%) | $11.21 M(+9.1%) |
| Jun 2017 | - | $2.90 M(-15.3%) | $10.27 M(+11.6%) |
| Mar 2017 | - | $3.43 M(+53.9%) | $9.21 M(+32.1%) |
| Dec 2016 | $6.97 M(+11.3%) | $2.23 M(+29.8%) | $6.97 M(+10.5%) |
| Sep 2016 | - | $1.72 M(-6.5%) | $6.31 M(+5.6%) |
| Jun 2016 | - | $1.83 M(+53.9%) | $5.97 M(+7.6%) |
| Mar 2016 | - | $1.19 M(-23.8%) | $5.55 M(-11.4%) |
| Dec 2015 | $6.26 M(-9.1%) | $1.56 M(+13.3%) | $6.26 M(+2.7%) |
| Sep 2015 | - | $1.38 M(-2.4%) | $6.10 M(-0.4%) |
| Jun 2015 | - | $1.41 M(-25.8%) | $6.12 M(-4.7%) |
| Mar 2015 | - | $1.91 M(+36.2%) | $6.42 M(-6.8%) |
| Dec 2014 | $6.89 M(+199.8%) | $1.40 M(-0.4%) | $6.89 M(+9.2%) |
| Sep 2014 | - | $1.41 M(-18.0%) | $6.31 M(+16.9%) |
| Jun 2014 | - | $1.71 M(-27.8%) | $5.40 M(+29.3%) |
| Mar 2014 | - | $2.37 M(+189.0%) | $4.18 M(+81.8%) |
| Dec 2013 | $2.30 M(-41.1%) | $821.00 K(+66.9%) | $2.30 M(-3.4%) |
| Sep 2013 | - | $492.00 K(+0.2%) | $2.38 M(-17.3%) |
| Jun 2013 | - | $491.00 K(-0.6%) | $2.88 M(-14.4%) |
| Mar 2013 | - | $494.00 K(-45.3%) | $3.36 M(-12.8%) |
| Dec 2012 | $3.90 M(+42.2%) | $902.90 K(-8.8%) | $3.86 M(+3.5%) |
| Sep 2012 | - | $989.60 K(+1.6%) | $3.72 M(+9.8%) |
| Jun 2012 | - | $974.30 K(-1.4%) | $3.39 M(+9.6%) |
| Mar 2012 | - | $988.30 K(+28.1%) | $3.09 M(+9.1%) |
| Dec 2011 | $2.74 M | $771.70 K(+17.4%) | $2.84 M(-11.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2011 | - | $657.20 K(-3.0%) | $3.21 M(-3.0%) |
| Jun 2011 | - | $677.30 K(-7.2%) | $3.31 M(+1.1%) |
| Mar 2011 | - | $729.50 K(-36.6%) | $3.28 M(+0.4%) |
| Dec 2010 | $3.27 M(-8.0%) | $1.15 M(+52.3%) | $3.26 M(+14.7%) |
| Sep 2010 | - | $755.00 K(+17.5%) | $2.85 M(+4.5%) |
| Jun 2010 | - | $642.30 K(-10.3%) | $2.72 M(-15.3%) |
| Mar 2010 | - | $716.10 K(-2.2%) | $3.21 M(-2.8%) |
| Dec 2009 | $3.55 M(-21.8%) | $732.00 K(+15.9%) | $3.31 M(+6.0%) |
| Sep 2009 | - | $631.50 K(-44.2%) | $3.12 M(-13.0%) |
| Jun 2009 | - | $1.13 M(+39.8%) | $3.58 M(-10.5%) |
| Mar 2009 | - | $810.20 K(+48.4%) | $4.01 M(-13.6%) |
| Dec 2008 | $4.54 M(-20.5%) | $546.00 K(-50.2%) | $4.64 M(-11.9%) |
| Sep 2008 | - | $1.10 M(-29.5%) | $5.27 M(-4.7%) |
| Jun 2008 | - | $1.56 M(+7.9%) | $5.53 M(+3.5%) |
| Mar 2008 | - | $1.44 M(+22.8%) | $5.34 M(-4.0%) |
| Dec 2007 | $5.71 M(-7.8%) | $1.17 M(-13.4%) | $5.56 M(-5.7%) |
| Sep 2007 | - | $1.35 M(-1.0%) | $5.89 M(-1.7%) |
| Jun 2007 | - | $1.37 M(-17.7%) | $6.00 M(-5.2%) |
| Mar 2007 | - | $1.66 M(+10.2%) | $6.33 M(+0.9%) |
| Dec 2006 | $6.19 M(-36.7%) | $1.51 M(+3.5%) | $6.27 M(-29.9%) |
| Sep 2006 | - | $1.46 M(-14.2%) | $8.95 M(-1.9%) |
| Jun 2006 | - | $1.70 M(+5.7%) | $9.13 M(+1.6%) |
| Mar 2006 | - | $1.61 M(-61.6%) | $8.98 M(-12.2%) |
| Dec 2005 | $9.78 M(+24.6%) | $4.18 M(+156.1%) | $10.22 M(+26.0%) |
| Sep 2005 | - | $1.63 M(+5.2%) | $8.11 M(+1.8%) |
| Jun 2005 | - | $1.55 M(-45.5%) | $7.97 M(-9.3%) |
| Mar 2005 | - | $2.85 M(+37.5%) | $8.79 M(+15.0%) |
| Dec 2004 | $7.85 M(-5.8%) | $2.07 M(+38.8%) | $7.65 M(-2.2%) |
| Sep 2004 | - | $1.49 M(-37.1%) | $7.82 M(-7.7%) |
| Jun 2004 | - | $2.37 M(+39.4%) | $8.48 M(-1.8%) |
| Mar 2004 | - | $1.70 M(-24.3%) | $8.63 M(+4.8%) |
| Dec 2003 | $8.33 M(+47.4%) | $2.25 M(+4.7%) | $8.23 M(+4.7%) |
| Sep 2003 | - | $2.15 M(-15.0%) | $7.86 M(+16.9%) |
| Jun 2003 | - | $2.53 M(+93.7%) | $6.72 M(+11.1%) |
| Mar 2003 | - | $1.30 M(-30.5%) | $6.05 M(+5.3%) |
| Dec 2002 | $5.65 M(+85.1%) | $1.88 M(+85.5%) | $5.74 M(+48.6%) |
| Sep 2002 | - | $1.01 M(-45.4%) | $3.86 M(+9.2%) |
| Jun 2002 | - | $1.85 M(+85.5%) | $3.54 M(+52.4%) |
| Mar 2002 | - | $998.80 K(+45.7%) | $2.32 M(-12.6%) |
| Dec 2001 | $3.05 M(+72.2%) | - | - |
| Aug 2001 | - | $685.30 K(+7.5%) | $2.66 M(+15.0%) |
| May 2001 | - | $637.40 K(-9.2%) | $2.31 M(+8.0%) |
| Feb 2001 | - | $701.60 K(+11.1%) | $2.14 M(+20.0%) |
| Nov 2000 | $1.77 M(+74.1%) | $631.70 K(+86.8%) | $1.78 M(+18.8%) |
| Aug 2000 | - | $338.10 K(-27.6%) | $1.50 M(+10.1%) |
| May 2000 | - | $467.20 K(+35.6%) | $1.36 M(+24.0%) |
| Feb 2000 | - | $344.60 K(-1.4%) | $1.10 M(+7.8%) |
| Nov 1999 | $1.02 M(-25.5%) | $349.60 K(+74.2%) | $1.02 M(+52.2%) |
| Aug 1999 | - | $200.70 K(-1.4%) | $669.40 K(+42.8%) |
| May 1999 | - | $203.50 K(-23.3%) | $468.70 K(+76.7%) |
| Feb 1999 | - | $265.20 K | $265.20 K |
| Nov 1998 | $1.37 M | - | - |
FAQ
- What is Aurinia Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals annual SGA year-on-year change?
- What is Aurinia Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals quarterly SGA year-on-year change?
- What is Aurinia Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals TTM SGA year-on-year change?
What is Aurinia Pharmaceuticals annual SGA?
The current annual SGA of AUPH is $195.04 M
What is the all time high annual SGA for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high annual SGA is $196.37 M
What is Aurinia Pharmaceuticals annual SGA year-on-year change?
Over the past year, AUPH annual SGA has changed by -$1.33 M (-0.68%)
What is Aurinia Pharmaceuticals quarterly SGA?
The current quarterly SGA of AUPH is $39.64 M
What is the all time high quarterly SGA for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high quarterly SGA is $60.62 M
What is Aurinia Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, AUPH quarterly SGA has changed by -$2.64 M (-6.24%)
What is Aurinia Pharmaceuticals TTM SGA?
The current TTM SGA of AUPH is -$3.79 B
What is the all time high TTM SGA for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high TTM SGA is -$5.50 M
What is Aurinia Pharmaceuticals TTM SGA year-on-year change?
Over the past year, AUPH TTM SGA has changed by -$3.98 B (-2069.43%)